Australia’s women’s fast bowler Megan Schutt is given a two-match suspension after a breach of prescription medication requirements outside competitive play. The ban rules her out of Australia’s final T20I against New Zealand and her next WBBL match for the Adelaide Strikers, depending on scheduling.
Cricket Australia confirms the sanction and points to player accountability and compliance with sports science and sports medicine medication guidelines. Multiple outlets report that the matter is not linked to performance-enhancing drugs, and that Schutt apologises and accepts responsibility. ESPN Cricinfo adds that Schutt accepts the two-match ban due to a failure to adhere to requirements under the relevant guidelines, while several other reports summarise the same outcome in briefer terms.
Across the coverage, the core facts—two-match length, medication-breach context, and Schutt’s apology—are consistent. The main differences are in how much detail outlets provide about the guidelines and the competition schedule affected.
